文献速递先天性心脏病外科瓣膜外科

保留瓣膜与跨环补片修复法洛四联症的临床与超声心动图结局比较:系统综述与荟萃分析

Comparing clinical and echocardiographic outcomes following valve-sparing versus transannular patch repair of tetralogy of Fallot: a systematic review and meta-analysis.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

结果显示保留瓣膜组体外循环时间、通气时间、ICU及住院时间更短,死亡风险和肺动脉反流风险更低,多数其他结局两组相当。

要点

  • 保留瓣膜组较跨环补片组体外循环时间缩短(MD -14.97,95%CI -22.54至-7.41)。
  • 保留瓣膜组死亡风险为跨环补片组的0.40倍(RR 0.40,95%CI 0.27-0.60)。
  • 保留瓣膜组肺动脉反流风险为跨环补片组的0.35倍(RR 0.35,95%CI 0.26-0.46)。

核心结论

  • 该荟萃分析证实跨环补片修复后肺动脉瓣关闭不全风险增加,同时显示保留瓣膜修复与多项临床结局改善相关。

研究设计与样本

  • 系统检索PubMed、Embase、Scopus、Cochrane Central Register of Controlled Trials和Web of Science数据库,纳入比较传统跨环补片修复与保留瓣膜修复治疗法洛四联症的研究,采用随机效应模型进行荟萃分析。

主要发现

  • 保留瓣膜组较跨环补片组体外循环时间显著缩短(MD -14.97,95%CI -22.54至-7.41)。
  • 保留瓣膜组较跨环补片组通气时间缩短(MD -15.33,95%CI -30.20至-0.46)。
  • 保留瓣膜组较跨环补片组ICU停留时间缩短(MD -0.67,95%CI -1.29至-0.06)。
  • 保留瓣膜组较跨环补片组住院时间缩短(MD -2.30,95%CI -4.08至-0.52)。
  • 保留瓣膜组较跨环补片组死亡风险降低(RR 0.40,95%CI 0.27-0.60),肺动脉反流风险降低(RR 0.35,95%CI 0.26-0.46);多数其他临床与超声心动图结局两组相当。

临床怎么用

  • 该荟萃分析结果可为法洛四联症修复术中保留瓣膜策略与跨环补片策略的选择提供参考,但采用保留瓣膜方法的具体标准仍需进一步研究确定。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Transannular patch (TAP) repair of tetralogy of Fallot (ToF)relieves right ventricular tract obstruction but may lead to pulmonary regurgitation. Valve-sparing (VS) procedures can avoid this situation, but there is a potential for residual pulmonary stenosis. Our goal was to evaluate clinical and echocardiographic outcomes of TAP and VS repair for ToF. METHODS: A systematic search of the PubMed, Embase, Scopus, Cochrane Central Register of Controlled Trials and Web of Science databases was carried out to identify articles comparing conventional TAP repair and VS repair for ToF. Random-effects models were used to perform meta-analyses of the clinical and echocardiographic outcomes. RESULTS: Forty studies were included in this meta-analysis with data on 11 723 participants (TAP: 6171; VS: 5045). Participants who underwent a VS procedure experienced a significantly lower cardiopulmonary bypass time [mean difference (MD): -14.97; 95% confidence interval (CI): -22.54, -7.41], shorter ventilation duration (MD: -15.33; 95% CI: -30.20, -0.46) and shorter lengths of both intensive care unit (ICU) (MD: -0.67; 95% CI: -1.29, -0.06) and hospital stays (MD: -2.30; 95% CI: [-4.08, -0.52). There was also a lower risk of mortality [risk ratio: 0.40; 95% CI: (0.27, 0.60) and pulmonary regurgitation [risk ratio: 0.35; 95% CI: (0.26, 0.46)] associated with the VS group. Most other clinical and echocardiographic outcomes were comparable in the 2 groups. CONCLUSIONS: This meta-analysis confirms the well-established increased risk of pulmonary insufficiency following TAP repair while also demonstrating that VS repairs are associated with several improved clinical outcomes. Continued research can identify the criteria for adopting a VS approach as opposed to a traditional TAP repair.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Martins RS, Fatimi AS, Mahmud O, et al. Comparing clinical and echocardiographic outcomes following valve-sparing versus transannular patch repair of tetralogy of Fallot: a systematic review and meta-analysis. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38924512. doi:10.1093/icvts/ivae124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。